AstraZeneca has welcomed a new registration for its asthma therapies SYMBICORT TURBUHALER and SYMBICORT RAPIHALER (budesonide and formoterol) and will be hoping for a positive outcome at November's PBAC meeting. …
Latest Video
New Stories
-
Key week for 7CPA negotiations
November 12, 2019 - - Latest News -
Bowen maintains pressure on flash monitors
November 12, 2019 - - Latest News -
An emerging alignment of historic significance
November 12, 2019 - - Comment -
Novartis welcomes TGA approval ahead of PBAC outcome
November 12, 2019 - - Latest News -
Roche backs lung health advocacy project
November 12, 2019 - - Latest News -
Reducing submission 'churn' by getting rid of resubmissions?
November 11, 2019 - - Latest News -
US price reform stalls on key differences
November 11, 2019 - - Latest News